Selenium as an element in the treatment of ovarian cancer in women receiving chemotherapy

Gynecologic Oncology

Volumn 93, Issue 2, 2004, Pages 320-327

  Sieja, Krzysztof ^a   Talerczyk, Małgorzata ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Chemotherapy; Glutathione peroxidase; Hair; Malondialdehyde; Ovarian cancer; Selenium; Serum; Side effects

Indexed keywords

ANTIOXIDANT; CISPLATIN; CYCLOPHOSPHAMIDE; GLUTATHIONE PEROXIDASE; IMPROSULFAN TOSILATE; MALONALDEHYDE; SELENIUM; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ANOREXIA; ARTICLE; BLOOD CELL; CALCULATION; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; FLATULENCE; HAIR; HAIR LOSS; HUMAN; MALAISE; MUSCLE WEAKNESS; NAUSEA; NEUROTOXICITY; OTOTOXICITY; OVARY CANCER; OXIDATIVE STRESS; PRIORITY JOURNAL; SERUM; STATISTICAL SIGNIFICANCE; STOMATITIS; THROMBOCYTE COUNT; TINNITUS; VERTIGO; VOMITING;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD PLATELETS; CISPLATIN; CYCLOPHOSPHAMIDE; DIETARY SUPPLEMENTS; ERYTHROCYTES; FEMALE; GLUTATHIONE PEROXIDASE; HAIR; HUMANS; MALONDIALDEHYDE; MIDDLE AGED; OVARIAN NEOPLASMS; OXIDATIVE STRESS; SELENIUM;

EID: 1942508981     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2003.12.013     Document Type: Article

References (39)

1. Pilawski Z., Kośmider M., Kozlowski D. Cisplatin and adriamycin in the treatment of non-operable ovarian tumors. The first scientific meeting of obstetricians and gynecologists in Poznań, Heliodor Świecicki Days", Poznań 25-30.05. Pol. Gynecol. (Polish). 58(Suppl. 1):1987;98-201.
2. Shallon J., Juvekar A., Chitnis M. Selenium (Se) cytotoxicity in drug sensitive and drug resistant murine tumor. Cancer Biother. 10:1995;243-248.
3. Baldew G.S., van den Hamer C.J., Los G., Vermeulen N.P., de Goeij J.J., McVie J.G. Selenium-induced protection against cis-diaminedichloroplatinum (II) nephrotoxicity in mice and rats. Cancer Res. 49:1989;3020-3023.
4. Sieja K. Selenium (Se) deficiency in women with ovarian cancer undergoing chemotherapy and the influence of supplementation with this microelement on biochemical parameters. Pharmazie. 53:1998;473-476.
5. Vernie L.N., de-Goeij J.J., Zegres C., de-Vries M., Baldew G.S., McVie J.G. Cisplatin-induced changes of selenium levels and glutathione peroxidase activities in blood of testis tumor patients. Cancer Lett. 40:1987;89-91.
6. Young V.R. Selenium a case for its essentiality in man. N. Engl. J. Med. 304:1981;1228-1230.
7. Lachowicz L. Cisplatin adverse reactions in patients with cancer. Pol. Med. J. (Polish). 64:1989;25-26.
8. Roszkowski K., Piekutowski K. Free radicals. Defense activity of antioxidant vitamins in prevention and treatment of cancers. Contemp. Oncol. (Polish). 4:1999;143-144.
9. Burk R.F., Foster K.A., Greenfield P.M., Kiker K.W., Hammon J.P. Binding of simultaneously administered inorganic selenium and mercury to a rat plasma protein. Proc. Soc. Exp. Med. 144:1974;782-785.
10. Comb G.F. Jr., Clark L.C., Turnbull B.M. An analysis of cancer prevention by selenium. Biofactors. 14:2001;153-159.
11. Sheeehan T.M., Halls D.J. Measurement of selenium in clinical specimens. Ann. Clin. Biochem. 36(Pt 3):1999;301-305.
12. Fracescato H.D., Costa R.S., Rodrigues-Camargo S.M., Zanetti M.A., Lavrador M.A., Bianchi M.D. Effect of oral selenium administration on cisplatin-induced nephrotoxicity in rats. Pharmacol. Res. 43:2001;77-82.
13. Medcalf A.S., Wade M.H. Comparison of mutagenicity of N-methyl-N-nitrosourea and N-ethyl-nitrosourea in human diploid fibroblasts. Carcinogenesis. 4:1983;115-118.
14. Smith A.M., Chang M.P., Medeiros L.C. Generational differences in selenium status of women. Biol. Trace Elem. Res. 75:2000;157-165.
15. Kanias G.D., Kouri E. Biological evaluation of trace element data in human ovaries by statistical analysis. Biol. Trace Elem. Res. 52:1996;65-66.
16. Behne D., Gessner H., Kyrialopoulos A. Information on the selenium status of several body compartments of rats from selenium concentrations in blood fractions, hair and nails. J. Trace Elem. Med. Biol. 10:1996;174-179.
17. Beretta S. Cancer treatment medical guide. 10th ed. 1991;68-83 Farmitalia Carlo Erba-Erbamount, Milan.
18. Watkinson J.H. Fluorometric determination of selenium material with 2,3 diaminonaphtalene. Anal. Chem. 38:1966;92-97.
19. Danch A., Dróżdż M. Simplified fluorometric method for the determination of selenium in biological materials. Lab. Diagn. (Polish). 32:1996;524-529.
20. Paglia D.E., Valentine W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med. 70:1967;158-168.
21. Lawrence R.A., Burk R.F. Glutathione peroxidase activity in selenium-deficient rat liver. Biochem. Biophys. Res. Commun. 71:1976;952-958.
22. Okuma T., Steiner N., Baldini M. Studies on lipid peroxides in platelets. I. Method of assay and effect of storage. J. Lab. Clin. Med. 75:1970;283-290.
23. Stuart M.J., Murphy S., Oski F.A. A simple nonradioisotope technique for the determination of platelet life span. N. Engl. J. Med. 292:1975;1301-1313.
24. Jarzabek Z., Naskalski J.W. Selenium - a new parameter in clinical laboratory. Lab. Diagn. (Polish). 29:1991;50-55.
25. Dróżdż M., Tomala J., Jedryczko A., Banas K. Concentration of selenium and vitamin E in the serum of women with malignant genital neoplasm's and their family members. Pol. Gynecol. (Polish). 60:1989;301-305.
26. Das N.P., Ma C.W. Serum selenium concentrations in ovarian cancer patients using a simplified fluometric procedure. Biol. Trace Elem. Res. 1986;215-218.
27. Sundström H., Korpela H., Viinikka L., Kauppuila A. Serum selenium and glutathione peroxidase and plasma lipid peroxides in uterine, ovarian, and vulvae cancer, and their responses to antioxidants in patients with ovarian cancer. Cancer Lett. 24:1984;1-10.
28. Kośmider M., Malecha J., Szczypiński J., Wydra E., Sieja K., Borowiak D. Importance of selenium in combined treatment of ovarian neoplasma. Pol. Gynecol. (Polish). 32(Suppl. 1):1991;529-534.
29. Bednarek D., Kondracki M., Cakala S. Effect of selenium and vitamin E on white cells, serum concentration of several minerals and trace elements as well as immunological parameters in calves. Dtsch. Tierartl. Wochenschr. 103:1996;457-459.
30. Hu Y.J., Chen Y., Zhang Y.Q., Zhou M.Z., Song X.M., Zhang B.Z.et al. The protective role of selenium on the toxicity of cisplatin-contained chemotherapy regimen in cancer patients. Biol. Trace Elem. Res. 56:1997;331-341.
31. Wanik A., Wysocki J., Choraży M. The role of free radicals in human pathology. Pol. Med. J. (Polish). 45:1990;195-199.
32. Woźniak Z. The influence of selenium on the dynamics and growth morphology in transplantable kidney and breast cancers induced by aflatoxin in Wistar's rats - doctorial thesis - Medical Academy in Wroclaw (Polish), Wroclaw 1988:1-102.
33. Matsuda A., Kimura A., Itokawa Y. Influence of selenium o the acute cardiotoxicity of adriamycin in rats. Biol. Trace Elem. Res. 57:1997;157-167.
34. Knudsen C.A., Tappel A.L., North J.A. Multiple antioxidants protection against hems protein and lipid oxidation in kidney tissue. Free Radic. Biol. Med. 20:1996;165-173.
35. Kiremidijan-Schumacher L., Roy M., Wiske H.I., Cohen M.W., Slotzky G. Supplementation with selenium augments the function of natural killer and lymphokine-activated killer cells. Biol. Trace Elem. Res. 52:1996;227-239.
36. Avtsyn A.P., Zhanoronkov A.A., Strochkova L.S., Kornev A.V. Effect of sodium selenite on tumor cells in culture. Vopr. Onkol. (Mosk.). 32(8):1986;77-80.
37. Babenko G.A., Pogribny T.P., Maskakevich J.J. Effect of sodium selenite on the activity of antioxidant enzymes (superoxide dismutase, glutathione peroxidase) during hepatocarcinogenesis. Eksp. Onkol. (Mosk.). 8(4):1986;31-33.
38. Xue F.X., Zhang S.W. Selenium concentrations in serum, hair and tumor tissue from patients with ovarian tumors. Chun-Hua-Fu-Chan-Ko-Tsa-Chih. 26(5):1991;290-295.
39. Vadgama J.V., Wu Y., Shen D., Hsia S., Block J. Effect of selenium in combination with Adriamycin or Taxol on several different cancer cells. Anticancer Res. 20(3A):2000;1391-1414.